| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47c757b23cbbb06df098716ddf81eb48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16 |
| filingDate |
1995-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40bdf10a577565b689d3d619f0210df9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e44b63c8dc37b2ca9bf65b2b3f01b21b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d66a39518dd2712672ec8629201a82ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b98782bc75a0c0a912b10de1d885702 |
| publicationDate |
2004-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1374865-A1 |
| titleOfInvention |
Use of R,S-(+/-)-alpha-lipoic acid, R(+)-alpha-lipoic acid or S-(-)-alpha-lipoic acid in reduced or oxidised form, or their metabolites as well as their salts, esters or amides, for the treatment of hearing disorders |
| abstract |
The invention relates to the use of R, S (+/-) -α-lipoic acid, R - (+) - alpha-lipoic acid,nS - (-) - alpha-lipoic acid in reduced or oxidized form or its metabolitesnand their salts, esters, amides for the manufacture of medicaments for the treatment ofnDiseases caused by changes or disorders of the rheologicalnBlood properties such as blood viscosity, erythrocyte flexibility andnErythrocyte aggregation are conditional in particularnas well as tinnitus and hearing loss. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011147252-A1 |
| priorityDate |
1994-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |